Wednesday, April 6, 2011

TMX Group - Equity Financing Statistics March 2011

TORONTO, April 5 /CNW/ - TMX Group today announced its financing activity on Toronto Stock Exchange and TSX Venture Exchange for March 2011.

Toronto Stock Exchange and TSX Venture Exchange together welcomed 34 new listings in March 2011, including 10 from the mining sector. These companies are exploring in locations such as Brazil, Ukraine, Africa, Australia, Mexico, U.S. and Canada.

Toronto Stock Exchange welcomed 17 new listings in March 2011, up from 11 in March 2010 but down slightly from 21 in February 2011. Total financings in March 2011 increased 18% compared to March 2010 and 9% compared to last month. On a year-to-date basis, total financings on Toronto Stock Exchange exceeded 2010 levels by 18%. 

World markets mixed amid Japan nuke progress

BANGKOK (AP) -- World markets struggled to find direction Wednesday, with uncertainty over Japan's industrial production capabilities overshadowing its progress in containing a toxic radiation leak at a nuclear power complex.

Oil prices hovered above $108 a barrel in Asia after a U.S. crude supply report gave mixed signals about demand. In currencies, the dollar rose against the yen but slipped against the euro.

European shares were mixed in early trading. Britain's FTSE 100 was 0.2 percent higher to 6,016.95. Germany's DAX fell 0.1 percent to 7,169.26 and France's CAC-40 was down 0.6 percent to 4,018.45. Wall Street was headed higher, however. Dow Jones industrial futures gained 22 points to 12,349 and S&P 500 futures rose 2.8 points to 1,329.50.

Friday, April 1, 2011

Obama Administration Offered Market Solution for Medical Malpractice

In last month’s budget proposal, the Obama administration offered a solution: a plan to encourage evidence-based medicine by limiting the malpractice liability of doctors who follow clinical practice guidelines — in effect, granting them immunity.

Doctors love this proposal, and patients should too: When doctors follow good guidelines they are less likely to order too many or too few tests or to prescribe the wrong treatment.

Unfortunately, the proposal will not achieve the noble goal of providing quality care at a reasonable cost because the current guidelines, written by nonprofit medical groups and for-profit insurance companies, are not good enough.

For more details visit